Named on one round in the feed.
Since 2026-11-13
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Boston Medical Sciences Boston Medical Sciences develops advanced medical technologies, including a non-invasive virtual colonoscopy system using AI for colorectal cancer detection, targeting healthcare providers and institutions. | Series B Verified against 4 sources | $34.7M | 2026-11-13 | [ LEAD ] |